Singapore: The next Viralytics clinical study evaluating multi doses of CAVATAK administered by the intravenous route ...
Singapore: Pharmaxis received a complete response letter from the US FDA confirming that Bronchitol cannot yet be appro...
Singapore: Asia-Pacific, including Japan, China, India, New Zealand, South Korea and Australia, is the fastest growing r...
Singapore: CDC predicts that every year, one in every three adults in the age group of 65 or older falls and around 2 mi...
Industry forecasts by market analysts state that 80 percent of the multinational companies expect to gain a good share i...
Singapore: A recent report released by RnRMarketResearch.com has analyzed the Global Biochips Industry and forecasted th...
Singapore: Australia boasts an advanced healthcare system supported by both the public and private sector involvement. T...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted orphan drug designation by t...
Singapore: US-Australian drug discovery company, Novogen's drug candidate, Anisina, has progressed successfully in pre-c...
Singapore: Australia-based Cynata Therapeutics has made a breakthrough by devising a technique to mass manufacture stem ...
Over the past decade the world's centre of economic gravity has shifted from US and Europe to Asia at a speed and scale ...
Singapore: CSL announced that it has clinched a deal with the Victorian government to expand its Melbourne plasma manufa...
Singapore: Telezon's flagship SoloFlow Reconstitution Needle (polymer needle) has been accepted by Therapeutic Goods Aus...
Singapore: Australia based Allied Healthcare has started commercializing CardioCel into Europe after the Company receive...
Singapore: 22nd Century Group, a company that has developed pioneering technology for tobacco harm reduction and smoking...
Singapore: Cancer Council NSW, Australia's non-government cancer research funder, has granted almost $7 million to resea...
Singapore: US-Australian drug discovery company, Novogen, in conjunction with Australian paediatric cancer researchers, ...
Singapore: Australian drug discovery company, Novogen, has developed anti-tropomyosin drug candidate, Anisina, which has...
